Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (62)

1

Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2023

von Lai, Y. | Lee, Y. | Chen, I. | +5

2

Remdesivir plus dexamethasone is associated to improvement in the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status

enthalten in: Medicina clinica | 2023

von Bernal, E. | García-Villalba, E. | Pons, E. | +14

3

Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19 : retrospective observational cohort study

enthalten in: Journal of infection in developing countries | 2023

von Sattoju, N. | Gattu, S. | Merugu, S. | +2

4

Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone

enthalten in: Infectious diseases (London, England) | 2023

von Leding, C. | Bodilsen, J. | Brieghel, C. | +27

5

Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir

enthalten in: Annals of neurology | 2023

von Grundmann, A. | Wu, C. | Hardwick, M. | +9

CommentIn: Nat Rev Neurol. 2022 Dec;18(12):699. - PMID 36323922

6

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults : A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

enthalten in: Annals of internal medicine | 2022

von Potter, G. | Bonnett, T. | Rubenstein, K. | +41

7

Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy : A Prospective Controlled Nonrandomized Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Marrone, A. | Nevola, R. | Sellitto, A. | +17

8

Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Padilla, S. | Polotskaya, K. | Fernández, M. | +7

9

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment

enthalten in: The Journal of infection | 2022

von Yoon, J. | Yoo, J. | Lee, J. | +12

CommentIn: J Infect. 2022 Aug;85(2):174-211. - PMID 35513188

10

Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19 : A retrospective study

enthalten in: Respiratory medicine and research | 2022

von Yasuda, Y. | Hirayama, Y. | Uemasu, K. | +3

1
2
3
4
5
6
7
Nächster »
[7]